91 related articles for article (PubMed ID: 27176944)
21. Synthesis of targeted dibenzo[b,f]thiepines and dibenzo[b,f]oxepines as potential lead molecules with promising anti-breast cancer activity.
Ansari MI; Hussain MK; Arun A; Chakravarti B; Konwar R; Hajela K
Eur J Med Chem; 2015 Jun; 99():113-24. PubMed ID: 26067208
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
[TBL] [Abstract][Full Text] [Related]
23. New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK.
Batran RZ; Dawood DH; El-Seginy SA; Ali MM; Maher TJ; Gugnani KS; Rondon-Ortiz AN
Arch Pharm (Weinheim); 2017 Sep; 350(9):. PubMed ID: 28787092
[TBL] [Abstract][Full Text] [Related]
24. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
25. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
26. Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2.
Salerno S; Marini AM; Fornaciari G; Simorini F; La Motta C; Taliani S; Sartini S; Da Settimo F; García-Argáez AN; Gia O; Cosconati S; Novellino E; D'Ocon P; Fioravanti A; Orlandi P; Bocci G; Dalla Via L
Eur J Med Chem; 2015 Oct; 103():29-43. PubMed ID: 26318056
[TBL] [Abstract][Full Text] [Related]
27. Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors.
Zhang HQ; Gong FH; Li CG; Zhang C; Wang YJ; Xu YG; Sun LP
Eur J Med Chem; 2016 Feb; 109():371-9. PubMed ID: 26826581
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the potential bioactivity of a novel compound ER1626.
Wang L; Zeng Y; Wang T; Liu H; Xiao H; Xiang H
PLoS One; 2014; 9(1):e86509. PubMed ID: 24475135
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, pharmacological evaluation and docking studies of progesterone and testosterone derivatives as anticancer agents.
Jabeen M; Choudhry MI; Miana GA; Rahman KM; Rashid U; Khan HU; Arshia ; Sadiq A
Steroids; 2018 Aug; 136():22-31. PubMed ID: 29772243
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.
Han SY; Choi JW; Yang J; Chae CH; Lee J; Jung H; Lee K; Ha JD; Kim HR; Cho SY
Bioorg Med Chem Lett; 2012 Apr; 22(8):2837-42. PubMed ID: 22450128
[TBL] [Abstract][Full Text] [Related]
31. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic and antimicrobial evaluations of novel apoptotic and anti-angiogenic spiro cyclic 2-oxindole derivatives of 2-amino-tetrahydroquinolin-5-one.
Ghozlan SA; Mohamed MF; Ahmed AG; Shouman SA; Attia YM; Abdelhamid IA
Arch Pharm (Weinheim); 2015 Feb; 348(2):113-24. PubMed ID: 25664629
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
Ananth AH; Manikandan N; Rajan RK; Elancheran R; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Kabilan S
Chem Biodivers; 2020 Feb; 17(2):e1900659. PubMed ID: 31995280
[TBL] [Abstract][Full Text] [Related]
34. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
35. ZnO Nanoparticles Catalyst in the Synthesis of Bioactive Fused Pyrimidines as Anti-breast Cancer Agents Targeting VEGFR-2.
Dawood DH; Abbas EMH; Farghaly TA; Ali MM; Ibrahim MF
Med Chem; 2019; 15(3):277-286. PubMed ID: 30207239
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of novel 2-methoxyestradiol analogs as dual selective estrogen receptor modulators (SERMs) and antiangiogenic agents.
Lao K; Wang Y; Chen M; Zhang J; You Q; Xiang H
Eur J Med Chem; 2017 Oct; 139():390-400. PubMed ID: 28810190
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and anti-proliferative activity of 1-(4-methoxyphenyl)-12-hydroxymethyl-p-carborane derivatives.
Kaise A; Ohta K; Endo Y
Eur J Med Chem; 2016 Oct; 122():257-263. PubMed ID: 27371927
[TBL] [Abstract][Full Text] [Related]
38. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
Shi L; Wu TT; Wang Z; Xue JY; Xu YG
Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC.
Peng FW; Xuan J; Wu TT; Xue JY; Ren ZW; Liu DK; Wang XQ; Chen XH; Zhang JW; Xu YG; Shi L
Eur J Med Chem; 2016 Feb; 109():1-12. PubMed ID: 26741358
[TBL] [Abstract][Full Text] [Related]
40. Novel 5-anilinoquinazoline-8-nitro derivatives as inhibitors of VEGFR-2 tyrosine kinase: synthesis, biological evaluation and molecular docking.
Xi L; Zhang JQ; Liu ZC; Zhang JH; Yan JF; Jin Y; Lin J
Org Biomol Chem; 2013 Jul; 11(26):4367-78. PubMed ID: 23715382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
